NasdaqGS - Delayed Quote USD

OraSure Technologies, Inc. (OSUR)

5.50 -0.03 (-0.54%)
At close: April 24 at 4:00 PM EDT
5.38 -0.12 (-2.18%)
After hours: April 24 at 4:03 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
405,472.00
405,472.00
387,479.00
233,674.00
171,721.00
Cost of Revenue
233,820.00
233,820.00
239,041.00
116,074.00
69,853.00
Gross Profit
171,652.00
171,652.00
148,438.00
117,600.00
101,868.00
Operating Expense
128,238.00
128,238.00
153,681.00
129,249.00
108,144.00
Operating Income
43,414.00
43,414.00
-5,243.00
-11,649.00
-6,276.00
Other Income Expense
12,844.00
12,844.00
-10,432.00
2,357.00
2,752.00
Pretax Income
56,258.00
56,258.00
-15,675.00
-9,292.00
-3,524.00
Tax Provision
2,603.00
2,603.00
1,458.00
13,706.00
11,398.00
Net Income Common Stockholders
53,655.00
53,655.00
-17,133.00
-22,998.00
-14,922.00
Diluted NI Available to Com Stockholders
53,655.00
53,655.00
-17,133.00
-22,998.00
-14,922.00
Basic EPS
0.73
--
-0.24
-0.32
-0.22
Diluted EPS
0.72
--
-0.24
-0.32
-0.22
Basic Average Shares
73,348.00
--
72,505.00
71,981.00
67,505.00
Diluted Average Shares
74,389.00
--
72,505.00
71,981.00
67,505.00
Total Operating Income as Reported
32,684.00
32,684.00
-22,156.00
-10,164.00
-5,177.00
Total Expenses
362,058.00
362,058.00
392,722.00
245,323.00
177,997.00
Net Income from Continuing & Discontinued Operation
53,655.00
53,655.00
-17,133.00
-22,998.00
-14,922.00
Normalized Income
63,891.42
63,891.42
-3,771.73
-24,082.05
-15,724.27
EBIT
43,414.00
43,414.00
-5,243.00
-11,649.00
-6,276.00
EBITDA
64,353.00
64,353.00
10,293.00
846.00
3,438.00
Reconciled Cost of Revenue
233,820.00
233,820.00
239,041.00
116,074.00
69,853.00
Reconciled Depreciation
20,939.00
20,939.00
15,536.00
12,495.00
9,714.00
Net Income from Continuing Operation Net Minority Interest
53,655.00
53,655.00
-17,133.00
-22,998.00
-14,922.00
Total Unusual Items Excluding Goodwill
-10,730.00
-10,730.00
-16,913.00
1,485.00
1,099.00
Total Unusual Items
-10,730.00
-10,730.00
-16,913.00
1,485.00
1,099.00
Normalized EBITDA
75,083.00
75,083.00
27,206.00
-639.00
2,339.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-493.58
-493.58
-3,551.73
400.95
296.73
12/31/2020 - 11/17/1986

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMSI Merit Medical Systems, Inc.
74.03
-0.20%
 
UTMD Utah Medical Products, Inc.
67.16
-0.59%
 
ICUI ICU Medical, Inc.
96.72
-1.06%
 
EMBC Embecta Corp.
10.89
+0.09%
 
ANGO AngioDynamics, Inc.
5.87
-2.65%
 
AZTA Azenta, Inc.
52.09
-0.86%
 
STVN Stevanato Group S.p.A.
27.31
+0.33%
 
XRAY DENTSPLY SIRONA Inc.
30.92
+0.19%
 
HAE Haemonetics Corporation
86.22
+1.35%
 
ATR AptarGroup, Inc.
140.01
+0.19%